Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

PD-1/PD-L1 Inhibitor C1

PD-1/PD-L1 Inhibitor C1

$109.00
A potent and selective small molecule inhibitor of the PD-1/PD-L1 protein/protein interactions.
Catalog No. Unit Price Qty
M60312-2s 2 mg solid $109.00

Details

Product Information
Molecular Weight: 475.58
Formula: C29H33NO5
Purity: ≥98%
CAS#: 1675201-83-8
Solubility: DMSO up to 100 mM; Water up to 100 mM
Chemical Name: (S)-1-(2,6-dimethoxy-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

PD-1/PD-L1 inhibitor C1 is a potent and selective small molecule inhibitor of the PD-1/PD-L1 protein/protein interactions with IC50 < 100 nM (PD-1/PD-L1 Homogenous Time-Resolved Fluorescence (HTRF) binding assay). It may potentially be useful in the treatment of cancer as well as infectious diseases such as hepatitis C. The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction plays a dominant role in the suppression of T cell responses, especially in a tumor microenvironment, protecting tumor cells from lysis.

How to Use:

In vitro: PD-1/PD-L1 Inhibitor C1 was used at 10 µM final concentration in various assays.
In vivo: n/a

Reference:

  1. 1. Chupak, L.S. and Zheng, X. Compounds useful as immunomodulators. WO 2015/034820 (2015). 


PD1-PDL1-C1_spec.pdf      


Products are for research use only. Not for human use.

Description

Details

Product Information
Molecular Weight: 475.58
Formula: C29H33NO5
Purity: ≥98%
CAS#: 1675201-83-8
Solubility: DMSO up to 100 mM; Water up to 100 mM
Chemical Name: (S)-1-(2,6-dimethoxy-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

PD-1/PD-L1 inhibitor C1 is a potent and selective small molecule inhibitor of the PD-1/PD-L1 protein/protein interactions with IC50 < 100 nM (PD-1/PD-L1 Homogenous Time-Resolved Fluorescence (HTRF) binding assay). It may potentially be useful in the treatment of cancer as well as infectious diseases such as hepatitis C. The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction plays a dominant role in the suppression of T cell responses, especially in a tumor microenvironment, protecting tumor cells from lysis.

How to Use:

In vitro: PD-1/PD-L1 Inhibitor C1 was used at 10 µM final concentration in various assays.
In vivo: n/a

Reference:

  1. 1. Chupak, L.S. and Zheng, X. Compounds useful as immunomodulators. WO 2015/034820 (2015). 


PD1-PDL1-C1_spec.pdf      


Products are for research use only. Not for human use.

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: